Elevance Health ELV
$425.62 −$6.38 (-1.48%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $425.62 0.00%
Open$421.47
Prev close$432.00
Day range$421.47 – $430.69
Volume1.44M
Market cap$91.96B
P/E (TTM)18.1
Dividend yield1.61%
Analyst view
ConsensusBuy
Analysts13
Average target$486.00+14.2% vs. price
- Buy 69%
- Hold 31%
Low $449.00Now $425.62Avg $486.00High $523.00
Recent rating changes
The last 20 actions on file set price targets from $424.00 to $523.00, averaging $478.90.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 4 Nov 2026 | Bernstein | BUY | $520.00 |
| 27 Oct 2026 | Wells Fargo | BUY | $492.00 |
| 26 Oct 2026 | Wells Fargo | BUY | $492.00 |
| 23 Oct 2026 | TD Cowen | BUY | $495.00 |
| 23 Oct 2026 | Mizuho Securities | BUY | $490.00 |
| 22 Oct 2026 | UBS | BUY | $523.00 |
| 22 Oct 2026 | BofA Securities | BUY | $500.00 |
| 22 Oct 2026 | Truist Financial | BUY | $500.00 |
| 22 Oct 2026 | Morgan Stanley | HOLD | $449.00 |
| 22 Oct 2026 | Goldman Sachs | HOLD | $451.00 |
| 22 Oct 2026 | Barclays | BUY | $472.00 |
| 21 Oct 2026 | Wells Fargo | BUY | $473.00 |
| 21 Oct 2026 | BofA Securities | BUY | $480.00 |
| 21 Oct 2026 | Guggenheim | BUY | $485.00 |
| 21 Oct 2026 | RBC Capital | HOLD | $455.00 |
| 12 Oct 2026 | Guggenheim | BUY | $460.00 |
| 7 Oct 2026 | Barclays | BUY | $469.00 |
| 7 Oct 2026 | RBC Capital | HOLD | $424.00 |
| 5 Oct 2026 | Bernstein | BUY | $488.00 |
| 18 Sep 2026 | UBS | BUY | $460.00 |
No comments yet — be the first to weigh in on ELV.
Sign in to join the discussion.